A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

NCT01412333 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

835

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: Interferon beta-1a
DRUG: Ocrelizumab-matching placebo
DRUG: Ocrelizumab
DRUG: Interferon beta-1a-matching placebo

Sponsor

Hoffmann-La Roche